دورية أكاديمية
أعرض في EDS

Effects of infrared laser moxibustion on cancer-related fatigue in breast cancer survivors: Study protocol for a randomized controlled trial.

التفاصيل البيبلوغرافية
العنوان: Effects of infrared laser moxibustion on cancer-related fatigue in breast cancer survivors: Study protocol for a randomized controlled trial.
المؤلفون: Mao H; Shanghai University of Traditional Chinese Medicine, School of Acupuncture-Moxibustion and Tuina, Shanghai, China., Mao JJ; Memorial Sloan Kettering Cancer Center, Bendheim Integrative Medicine Center, New York, NY., Chen J; Shanghai University of Traditional Chinese Medicine, Institute of Disciplinary Science., Li Q; Memorial Sloan Kettering Cancer Center, Bendheim Integrative Medicine Center, New York, NY., Chen X; Shanghai University of Traditional Chinese Medicine, School of Public Health., Shen X; Shanghai University of Traditional Chinese Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine., Zhao L; Shanghai University of Traditional Chinese Medicine, School of Acupuncture-Moxibustion and Tuina, Shanghai, China., Wei J; Shanghai University of Traditional Chinese Medicine, School of Acupuncture-Moxibustion and Tuina, Shanghai, China., Shen X; Shanghai University of Traditional Chinese Medicine, School of Acupuncture-Moxibustion and Tuina, Shanghai, China.; Shanghai Research Center of Acupuncture and Meridian, Shanghai, China.
المصدر: Medicine [Medicine (Baltimore)] 2019 Aug; Vol. 98 (34), pp. e16882.
نوع المنشور: Clinical Trial Protocol; Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
مواضيع طبية MeSH: Breast Neoplasms/*complications , Cancer Survivors/*psychology , Fatigue/*therapy , Infrared Rays/*therapeutic use , Moxibustion/*methods, China ; Female ; Humans ; Quality of Life ; Randomized Controlled Trials as Topic
مستخلص: Background: Cancer-related fatigue (CRF) is the most common and distressing symptom associated with cancer treatment that breast cancer survivors (BCS) experience. We previously found that laser moxibustion may be efficacious for CRF. The primary aim of this study is to determine the specific efficacy of 10.6 μm infrared laser moxibustion on CRF. The secondary aim is to evaluate the effect of infrared laser moxibustion on co-existing symptoms that BCS experience.
Methods: We will conduct a randomized, sham-controlled, three-arm trial of infrared laser moxibustion (ILM) against sham ILM (SILM) and waitlist control (WLC) among BCS with moderate to severe fatigue. The two intervention groups will receive either real or sham infrared laser moxibustion on four acupoints (i.e., ST36 [bilateral], CV4, and CV6) for 20 minutes each session for 6 weeks (twice per week). The primary endpoint is the change in fatigue score from Baseline to Week 6 as measured by the Chinese version of the Brief Fatigue Inventory (BFI-C). Our secondary aim is to compare the severity of co-morbidities (e.g., depression, insomnia, and pain) among the 3 groups.
Discussion: The results of our trial will establish evidence for the efficacy of infrared laser moxibustion for CRF, a very common and challenging symptom.
Trial Registration Number: NCT03553355.
References: Breast Cancer Res Treat. 2007 Dec;106(3):413-8. (PMID: 17377841)
Cancer. 2009 Aug 15;115(16):3631-9. (PMID: 19517460)
Eur J Cancer. 2018 Sep;101:47-54. (PMID: 30014974)
Asian Nurs Res (Korean Soc Nurs Sci). 2012 Dec;6(4):121-7. (PMID: 25031113)
Biometrics. 1982 Dec;38(4):963-74. (PMID: 7168798)
Holist Nurs Pract. 2017 Mar/Apr;31(2):66-79. (PMID: 28181972)
Eur J Oncol Nurs. 2016 Dec;25:16-23. (PMID: 27865248)
Support Care Cancer. 2018 Oct;26(10):3423-3430. (PMID: 29675547)
J Clin Oncol. 1993 Mar;11(3):570-9. (PMID: 8445433)
Cancer. 2006 Feb 15;106(4):751-8. (PMID: 16400678)
Brain Behav Immun. 2012 May;26(4):573-9. (PMID: 22293459)
J Natl Cancer Inst Monogr. 2004;(32):40-50. (PMID: 15263040)
Cancer Prev Res (Phila). 2012 Oct;5(10):1173-82. (PMID: 22827974)
JAMA Oncol. 2017 Jul 01;3(7):961-968. (PMID: 28253393)
Hormones (Athens). 2009 Jan-Mar;8(1):7-22. (PMID: 19269917)
J Exp Clin Cancer Res. 2008 Aug 29;27:32. (PMID: 18759983)
Cancer. 1999 Mar 1;85(5):1186-96. (PMID: 10091805)
Ann Intern Med. 2008 Feb 19;148(4):295-309. (PMID: 18283207)
Eur J Cancer. 2002 Jan;38(1):27-43. (PMID: 11750837)
BMJ. 2001 Sep 1;323(7311):486-7. (PMID: 11532841)
Psychiatry Res. 1989 May;28(2):193-213. (PMID: 2748771)
Breast Cancer Res Treat. 2007 Oct;105(2):209-19. (PMID: 17203386)
Complement Ther Med. 2006 Sep;14(3):213-9. (PMID: 16911902)
J Comp Eff Res. 2015 Mar;4(2):157-66. (PMID: 25825844)
Semin Hematol. 2000 Oct;37(4 Suppl 6):14-7. (PMID: 11068951)
J Psychosom Res. 2002 Feb;52(2):69-77. (PMID: 11832252)
Integr Cancer Ther. 2014 May;13(3):193-200. (PMID: 24282102)
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):842-6. (PMID: 12649083)
Support Care Cancer. 2014 May;22(5):1429-40. (PMID: 24609979)
Curr Opin Oncol. 2017 Jul;29(4):235-242. (PMID: 28459738)
Genes Chromosomes Cancer. 2013 Jul;52(7):595-609. (PMID: 23629941)
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. (PMID: 26808342)
Cancer. 2015 Feb 1;121(3):476-84. (PMID: 25367403)
Cancer. 2016 Dec 1;122(23):3667-3672. (PMID: 27495269)
J Clin Oncol. 2010 Aug 10;28(23):3671-2. (PMID: 20625135)
J Pain Symptom Manage. 2004 Apr;27(4):322-32. (PMID: 15050660)
Sleep Med. 2014 May;15(5):565-9. (PMID: 24759325)
J Altern Complement Med. 2010 Oct;16(10):ST1-14. (PMID: 20954957)
J Aging Res. 2014;2014:403253. (PMID: 24693429)
Evid Based Complement Alternat Med. 2012;2012:857804. (PMID: 22203882)
BMJ. 2001 Sep 1;323(7311):485-6. (PMID: 11532840)
Pain. 1996 Oct;67(2-3):407-16. (PMID: 8951936)
Medicine (Baltimore). 2016 Mar;95(9):e2901. (PMID: 26945382)
BMC Complement Altern Med. 2014 Jan 08;14:7. (PMID: 24400734)
Pain. 1983 Oct;17(2):197-210. (PMID: 6646795)
CA Cancer J Clin. 2017 Jan;67(1):7-30. (PMID: 28055103)
Explore (NY). 2007 Jul-Aug;3(4):372-7. (PMID: 17681257)
Altern Ther Health Med. 2010 Nov-Dec;16(6):22-7. (PMID: 21280459)
J Natl Compr Canc Netw. 2015 Aug;13(8):1012-39. (PMID: 26285247)
Support Care Cancer. 2013 Oct;21(10):2913-23. (PMID: 23868190)
PLoS One. 2012;7(7):e40186. (PMID: 22808115)
J Cancer Surviv. 2018 Dec;12(6):744-752. (PMID: 30182150)
معلومات مُعتمدة: P30 CA008748 United States CA NCI NIH HHS
سلسلة جزيئية: ClinicalTrials.gov NCT03553355
تواريخ الأحداث: Date Created: 20190824 Date Completed: 20190903 Latest Revision: 20240719
رمز التحديث: 20240719
مُعرف محوري في PubMed: PMC6716733
DOI: 10.1097/MD.0000000000016882
PMID: 31441863
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-5964
DOI:10.1097/MD.0000000000016882